Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis

Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis

Abstract Background Physical and emotional symptoms are prevalent in patients with kidney-dysfunction requiring dialysis (KDRD) and the rigors of thrice-weekly hemodialysis (HD) may contribute to deteriorated health-related quality of life. Less intensive HD schedules might be associated with lower...

Full description

Bibliographic Details
Main Authors: Mariana Murea, Benjamin R. Highland, Wesley Yang, Emily Dressler, Gregory B. Russell
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Nephrology
Subjects:
Incremental
Hemodialysis
Patient-reported outcomes
Online Access:https://doi.org/10.1186/s12882-022-02946-w

Internet

https://doi.org/10.1186/s12882-022-02946-w

Similar Items